申请人:Pfizer Inc.
公开号:US05338740A1
公开(公告)日:1994-08-16
The present invention relates to novel heterocyclic derivatives of the formula Ar--W--Het wherein Ar, W and Het are as defined below, and related compounds, pharmaceutical compositions comprising such compounds, and the use of such compounds as regulators of the action of angiotensin II in mammals. The compounds of this invention are useful in the treatment and prevention of hypertension, glaucoma, renal disease, congestive heart failure, cognitive dysfunction, and other conditions in which the action of angiotensin II is implicated. This invention also relates to pharmaceutical compositions containing these compounds and to methods of inhibiting angiotensin II in mammals by administration of such compounds.
本发明涉及公式Ar-W-Het的新型杂环衍生物,其中Ar,W和Het如下所定义,以及相关化合物,包含这些化合物的药物组合物,以及这些化合物作为对哺乳动物中血管紧张素II作用的调节剂的用途。本发明的化合物在治疗和预防高血压、青光眼、肾脏疾病、充血性心力衰竭、认知功能障碍以及其他血管紧张素II作用涉及的疾病中具有用途。本发明还涉及含有这些化合物的药物组合物以及通过给予这些化合物的方式在哺乳动物中抑制血管紧张素II的方法。